Bristol Myers Squibb Files Proxy Materials
Ticker: CELG-RI · Form: DEFA14A · Filed: Mar 26, 2025 · CIK: 14272
| Field | Detail |
|---|---|
| Company | Bristol Myers Squibb Co (CELG-RI) |
| Form Type | DEFA14A |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
Related Tickers: BMY
TL;DR
BMS filed proxy docs, no fee. Standard procedure.
AI Summary
Bristol Myers Squibb Company filed a Definitive Additional Materials proxy statement on March 26, 2025. This filing is related to the company's proxy materials and does not involve a fee, as indicated by the 'No fee required' checkbox. The filing is made under the Securities Exchange Act of 1934.
Why It Matters
This filing is a standard procedural document for Bristol Myers Squibb, indicating ongoing corporate governance activities and shareholder communication processes.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would inherently increase risk.
Key Players & Entities
- BRISTOL MYERS SQUIBB CO (company) — Registrant
- 0001140361-25-010440 (filing_id) — Accession Number
- 20250326 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for Bristol Myers Squibb?
This is a Definitive Additional Materials proxy statement filed under Schedule 14A.
When was this filing submitted to the SEC?
The filing was submitted on March 26, 2025.
Is there a filing fee associated with this document?
No, the filing indicates that no fee is required.
Under which section of the Securities Exchange Act is this filing made?
This filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934.
What is the standard industrial classification for Bristol Myers Squibb?
The standard industrial classification for Bristol Myers Squibb is Pharmaceutical Preparations [2834].
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 26, 2025 regarding BRISTOL MYERS SQUIBB CO (CELG-RI).